RELMADA THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q1 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Relmada Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2013 to Q3 2024.
  • Relmada Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 30.2M shares, a 0.25% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 30.2M +75K +0.25% Nov 4, 2024 10-Q 2024-11-07
Q2 2024 30.2M +75K +0.25% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 30.2M +75K +0.25% Mar 15, 2024 10-K 2024-03-19
Q3 2023 30.1M 0 0% Nov 6, 2023 10-Q 2023-11-08
Q2 2023 30.1M +38.7K +0.13% Aug 3, 2023 10-Q 2023-08-08
Q1 2023 30.1M +730K +2.49% Mar 20, 2023 10-K 2023-03-23
Q3 2022 30.1M +12.6M +71.7% Nov 7, 2022 10-Q 2022-11-10
Q2 2022 30.1M +12.6M +72% Aug 9, 2022 10-Q 2022-08-11
Q1 2022 29.4M +12.6M +75.4% Mar 21, 2022 10-K 2022-03-25
Q3 2021 17.5M +1.29M +7.94% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 17.5M +1.45M +9.04% Aug 6, 2021 10-Q 2021-08-10
Q1 2021 16.7M +1.81M +12.1% Mar 15, 2021 10-K 2021-03-24
Q3 2020 16.2M -23.3M -59% Nov 9, 2020 10-Q 2020-11-12
Q2 2020 16M Aug 5, 2020 10-Q 2020-08-12
Q1 2020 14.9M -18.3M -55.1% Mar 26, 2020 10-KT 2020-03-26
Q3 2019 39.6M +27M +215% Sep 24, 2019 10-K 2019-09-24
Q1 2019 33.3M +20.7M +165% May 14, 2019 10-Q 2019-05-15
Q4 2018 30.3M +17.7M +141% Feb 13, 2019 10-Q 2019-02-13
Q3 2018 12.5M +4.75K +0.04% Sep 28, 2018 10-K 2018-09-28
Q1 2018 12.5M +509K +4.23% May 14, 2018 10-Q 2018-05-14
Q4 2017 12.5M +512K +4.25% Feb 12, 2018 10-Q 2018-02-12
Q3 2017 12.5M +510K +4.24% Sep 28, 2017 10-K 2017-09-28
Q1 2017 12M +20.8K +0.17% May 15, 2017 10-Q 2017-05-15
Q4 2016 12M +36.8K +0.31% Jan 20, 2017 10-Q 2017-02-10
Q3 2016 12M +1.22M +11.3% Sep 9, 2016 10-K 2016-09-09
Q1 2016 12M -41.7M -77.6% May 9, 2016 10-Q 2016-05-09
Q4 2015 12M -41.7M -77.6% Feb 5, 2016 10-Q 2016-02-05
Q3 2015 10.8M -29.5M -73.2% Sep 11, 2015 10-K 2015-09-11
Q1 2015 53.7M +25.2M +88.6% May 15, 2015 10-Q 2015-05-15
Q4 2014 53.7M +25.2M +88.4% Feb 13, 2015 10-Q 2015-02-13
Q3 2014 40.3M Sep 2, 2014 10-KT 2014-09-09
Q1 2014 28.5M +5M +21.3% Apr 14, 2014 10-Q 2014-04-15
Q4 2013 28.5M Jan 14, 2014 10-Q 2014-01-13
Q2 2013 23.5M Jul 10, 2013 10-Q 2013-07-12
Q1 2013 23.5M May 2, 2013 10-Q 2013-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.